


Capital Group: Is 'big tech' te groot geworden?
Regelgevingsrisico’s nemen toe voor ‘s werelds grootste techbedrijven. Welke implicaties heeft dit voor beleggers?
Capital Group : Interview with Rob Lovelace on the year ahead
Investors who rode out the 2020 market turmoil know the value of patience in the face of adversity. A recession and bear market was followed by the fastest rebound in history with US equity markets hitting new record highs in Q4 2020 and into 2021.
Capital Group : Biden's new administration : Priorities emerge under new leadership
As U.S. President Joe Biden takes office, the prospects for his policy agenda appear more robust than previously thought, following a Georgia runoff election that flipped control of the U.S. Senate.
Capital Group : 2021 Outlook : Turning points on the road to recovery
With the wreckage of 2020 in the rearview mirror, investor optimism for the new year is high. After all, how could it possibly be any worse than a year marked by a deadly pandemic, a brutal recession and one of the steepest bear markets in history?
Capital Group 2021 outlook: Keerpunten op de weg naar herstel
Vooruitzichten voor de economieën, markten en ondernemingen in 2021.
Capital Group : 'New defensive' investments in three charts
Traditionally, defensive stocks and sectors are ones that have been able to retain value despite economic upheavals. However, 2020 has seen significant headwinds for such investments, with value and dividend stocks no longer considered safe havens.
Capital Group: Defensief investeren in tijden van disruptie
Zijn disruptors de volgende generatie defensieve aandelen?
Capital Group : U.S. election results bring policy priorities into focus
Now that the results of last week’s U.S. elections are coming into focus, investor attention is shifting to the policy implications of a Joe Biden presidency. Bottom line: Don’t expect big, sweeping changes in the years ahead.
Capital Group : Recovery watch: When will growth return?
COVID-19 has forced economists to become students of virology.
“The virus is the economy,” says Capital Group U.S. economist Jared Franz.
Capital Group: Een blik op 2030: Snellere innovatie in de gezondheidszorg
De vooruitgang in gentechnologie, medicijnontwikkeling, diagnostiek en telegeneeskunde maakt ontwikkelingen in de gezondheidszorg spannender dan ooit.